The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrincess Priv Regulatory News (PEYS)

Share Price Information for Princess Priv (PEYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 905.00
Bid: 888.00
Ask: 922.00
Change: 1.00 (0.11%)
Spread: 34.00 (3.829%)
Open: 904.00
High: 0.00
Low: 0.00
Prev. Close: 905.00
PEYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV increases by 0.2%

26 Jun 2018 07:00

RNS Number : 4865S
Princess Private Equity Holding Ltd
26 June 2018
 

News Release

Guernsey, 26 June 2018

 

NAV increases by 0.2%

 

· Princess Private Equity Holding Limited's (Princess) net asset value increased by 0.2% to EUR 11.04 per share

· Portfolio developments (0.1%) and currency movements (0.4%) were positive

· Princess received distributions of EUR 6.4 million and invested EUR 21.8 million over the reporting period

 

Princess received distributions of EUR 6.4 million during the month, including EUR 2.4 million in proceeds from the partial sale of shares in Black Knight Financial Services, a US-based provider of integrated technology, services, data and analytics to lenders and servicers in the mortgage and real estate industries. The remaining EUR 4.0 million of distributions came predominantly from Princess' mature legacy fund portfolio.

 

Princess invested a total of EUR 21.8 million during the month, of which EUR 17.8 million was invested in the previously announced investment Hearthside Food Solutions ("Hearthside") alongside Charlesbank Capital Partners. Hearthside is the largest independent bakery in the US and produces a broad range of high-quality nutrition bars, cookies, cereals and other baked foods and snacks for some of the world's premier food brands. Following the investment, Partners Group and Charlesbank will work closely with Hearthside's management team on a number of value creation initiatives. These will be focused on promoting organic growth by providing customers with an even wider range of innovative product solutions, executing select add-on acquisitions to further expand the business into adjacent industries and geographies, and optimizing existing manufacturing processes. EUR 1.6 million was invested in existing portfolio company Cerba HealthCare, a European medical laboratory services operator, to fund Cerba's acquisition of Bio7. Bio7, a leader in the French routine clinical pathology market, is considered an attractive acquisition for Cerba, given its scale and market position. This strategic investment is in line with Cerba's value creation plan to drive a France-focused M&A consolidation strategy.

 

Further information is available in the monthly report, which can be accessed via: http://www.princess-privateequity.net/financialreports.

 

Ends.

 

About Princess

Princess is an investment holding company founded in 1999 and domiciled in Guernsey. It invests, inter alia, in private equity and private debt investments. Princess is advised in its investment activities by Partners Group, a global private markets investment management firm with EUR 61.9 billion in investment programs under management in private equity, private debt, private real estate and private infrastructure. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS for the Sterling Quote).

 

Contacts

Princess Private Equity Holding Limited:

princess@partnersgroup.com

www.princess-privateequity.net

 

Registered Number: 35241

 

LEI: 54930038LU8RDPFFVJ57

 

Investor relations contact

George Crowe

Phone: +44 (0)20 7575 2771

Email: george.crowe@partnersgroup.com

 

Media relations contact

Jenny Blinch

Phone: +44 207 575 2571

Email: jenny.blinch@partnersgroup.com

www.partnersgroup.com

 

This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

 

This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of Princess' website nor the contents of any website accessible from hyperlinks on Princess' website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRUVRURWWANUAR
Date   Source Headline
28th Apr 20217:00 amRNSCorrection to the Notes of the Notice of AGM
23rd Apr 20217:00 amRNSNotice of Annual General Meeting
15th Apr 20217:00 amRNSDeclaration of first interim dividend for FY 2021
1st Apr 20217:00 amRNSCompliance with Model Code
1st Apr 20217:00 amRNSTotal Voting Rights
31st Mar 202111:20 amRNSPartners Group to sell GlobalLogic
31st Mar 20217:32 amRNSDiscussions to exit investment in Cerba HealthCare
24th Mar 20217:00 amRNSNAV increases by 0.9% in February
22nd Mar 20217:00 amRNSPrincess publishes Annual Report 2020
1st Mar 20217:00 amRNSTotal Voting Rights
24th Feb 20217:00 amRNSNAV increases by 0.1% in January
16th Feb 20217:00 amRNSQ4 2020 quarterly results presentation
10th Feb 20217:00 amRNSQ4 2020 quarterly results presentation
1st Feb 20217:00 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSNAV increases by 3.1% in December
4th Jan 20217:00 amRNSCompliance with Model Code
4th Jan 20217:00 amRNSTotal Voting Rights
23rd Dec 20207:00 amRNSNAV increases by 3.1% in November
1st Dec 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSPrincess publishes October NAV
19th Nov 20202:56 pmRNSDividend Declaration
16th Nov 20207:00 amRNSQ3 2020 quarterly results presentation
4th Nov 20207:00 amRNSQ3 2020 quarterly results presentation
2nd Nov 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNAV increases by 3.8% in September
1st Oct 20207:00 amRNSCompliance with Model Code
1st Oct 20207:00 amRNSTotal Voting Rights
25th Sep 20207:00 amRNSNAV increases by 3.1% in August
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20207:00 amRNSNAV increases by 2.3% in July
25th Aug 20207:00 amRNSPartners Group to sell PCI Pharma Services
17th Aug 20207:00 amRNSPrincess publishes Half-Year Report 2020
7th Aug 20207:00 amRNSPrincess Q2 2020 Results Presentation
3rd Aug 20207:00 amRNSTotal Voting Rights
28th Jul 20207:00 amRNSNew Investment Management Agreement
24th Jul 20207:00 amRNSNAV increases by 2.9% in June
14th Jul 20204:38 pmRNSPrice Monitoring Extension
10th Jul 20204:45 pmRNSRevision to Dividend Payment Date
1st Jul 20207:00 amRNSCompliance with Model Code
1st Jul 20207:00 amRNSTotal Voting Rights
25th Jun 20207:00 amRNSNAV increases by 3.0% in May
23rd Jun 20207:00 amRNSDividend Declaration
19th Jun 20204:37 pmRNSPrice Monitoring Extension
11th Jun 20207:00 amRNSExit of Action closed
8th Jun 202012:07 pmRNSSecond Price Monitoring Extn
8th Jun 202012:02 pmRNSPrice Monitoring Extension
5th Jun 20207:00 amRNSHolding(s) in Company
1st Jun 20207:00 amRNSTotal Voting Rights
27th May 20203:00 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSNAV increases by 5.6% in April

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.